Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roessner

Showing results (61-70 of 355) with videos related to

Pageof 36
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-PG Edel, A Roessner, B Deneke, et al.
Pathology, Research and Practice|January 1, 1982
Intermediate-sized filaments in cells of normal human colon mucosa, adenomas and carcinomasD B von Bassewitz, A Roessner, E Grundmann
Anatomy and Embryology|October 1, 1995
The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical studyC Häckel, K Radig, I Röse, et al.
FEBS Letters|August 7, 2002
Mutagenesis identifies a conserved tyrosine residue important for the activity of uroporphyrinogen III synthase from Anacystis nidulansCharles A Roessner, Krishan Ponnamperuma, A I Scott
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|November 1, 1981
[Radiological behaviour patterns of bone tumours (author's transl)]M Galanski, J Friemann, A Roessner, et al.
Cancer Gene Therapy|August 11, 2001
Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotypeS Krueger, U Kellner, F Buehling, et al.
Clinical & Experimental Metastasis|November 23, 2000
Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell linesA Kido, S Krueger, C Haeckel, et al.
Acta Orthopaedica Scandinavica|June 1, 1991
Parosteal osteosarcoma. 2-23-year follow-up of 33 patientsP Ritschl, C Wurnig, G Lechner, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|January 1, 1993
[Fibrous dysplasia versus osteofibrous dysplasia. Morphological, differential diagnostic and clinical aspects. Experiences from the Westfalen bone tumor registry]A Bosse, W Niesert, P Wuisman, et al.
Der Pathologe|May 1, 1984
[Solitary skeletal lesions as the initial manifestation of systemic hematologic diseases. A contribution to the differential pathologic diagnosis of malignant bone tumors]G Kittel, A Roessner, E Vollmer, et al.
Pageof 36

Showing results (61-70 of 355) with videos related to

Sort By:
Pageof 36
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-PG Edel, A Roessner, B Deneke, et al.
Pathology, Research and Practice|January 1, 1982
Intermediate-sized filaments in cells of normal human colon mucosa, adenomas and carcinomasD B von Bassewitz, A Roessner, E Grundmann
Anatomy and Embryology|October 1, 1995
The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical studyC Häckel, K Radig, I Röse, et al.
FEBS Letters|August 7, 2002
Mutagenesis identifies a conserved tyrosine residue important for the activity of uroporphyrinogen III synthase from Anacystis nidulansCharles A Roessner, Krishan Ponnamperuma, A I Scott
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|November 1, 1981
[Radiological behaviour patterns of bone tumours (author's transl)]M Galanski, J Friemann, A Roessner, et al.
Cancer Gene Therapy|August 11, 2001
Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotypeS Krueger, U Kellner, F Buehling, et al.
Clinical & Experimental Metastasis|November 23, 2000
Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell linesA Kido, S Krueger, C Haeckel, et al.
Acta Orthopaedica Scandinavica|June 1, 1991
Parosteal osteosarcoma. 2-23-year follow-up of 33 patientsP Ritschl, C Wurnig, G Lechner, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|January 1, 1993
[Fibrous dysplasia versus osteofibrous dysplasia. Morphological, differential diagnostic and clinical aspects. Experiences from the Westfalen bone tumor registry]A Bosse, W Niesert, P Wuisman, et al.
Der Pathologe|May 1, 1984
[Solitary skeletal lesions as the initial manifestation of systemic hematologic diseases. A contribution to the differential pathologic diagnosis of malignant bone tumors]G Kittel, A Roessner, E Vollmer, et al.
Pageof 36